US Patent 10208052 Compositions for activating pyruvate kinase
Patent 10208052 was granted and assigned to FORMA Therapeutics on February, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 20, 2018
0
Date of Patent
February 19, 2019
0
Patent Applicant
Patent Application Number
15926236
0
Patent Citations Received
•••
Patent Inventor Names
Tatiana Shelekhin
0
Gary Gustafson
0
Lorna Mitchell
0
Neal Green
0
Xiaozhang Zheng
0
David R. Lancia, Jr.
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10208052 Compositions for activating pyruvate kinase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.